| CDE ID | CDE Description | | * 421 | EDRN Participant ID (Go To: 1832) |
| 1832 | Participant initials: (Go To: 423) |
| * 423 | EDRN Protocol ID (Go To: 422) |
| * 422 | EDRN Site ID (Go To: 929) |
| * 929 | EDRN Staff ID of the person who collected the data: (Go To: 1066) |
| * 1066 | Date participant was determined to be ineligible (MM/DD/YYYY): (Go To: 2186) |
| * 2186 | Reason(s) for ineligibility: (Go To: 1097) |
| | | Permissible Values (value): | Collected less than minimum set of specimens (42) |
|
| | | | Participant did not meet age requirement (45) |
|
| | | | Participant did not complete the required questionnaires (111) |
|
| | | | Participant had one or more co-morbidity that limited their participation (112) |
|
| | | | Participant has an active cancer (excluding non-melanoma skin cancer or carcinoma in-situ of the cervix) (117) |
|
| | | | Participant has a history of pancreatic cancer (118) |
|
| | | | Participant is taking non-allowed steroids (119) |
|
| | | | Participant’s blood sugar was measured in a stressful situation (120) |
|
| | | | Participant has a significant medical illnesses that would compromise their study participation (121) |
|
| | | | Participant has a non-elevated confirmatory test (140) |
|
| | | | Participant did not meet criteria for NOD or hyperglycemia (150) |
|
| | | | Participant signed consent more than 90 days after the index PDM (151) |
|
| | | | Participant used anti-DM medication in the 548 days prior to the index lab (152) |
|
| | | | Participant did not have one or more glycemic parameters measured during the 548 days prior to the index lab without meeting inclusion criteria A, B, or C (153) |
|
| | | | Participant had a known past history of hyperglycemia and/or diabetes as defined by inclusion criteria A, B, or C (154) |
|
| | | | Other, specify: (97) (Go To: 2184) |
|
| * 2184 | Reason for ineligibility (Other, specify): (Go To: 1097) |
| 1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |